Magnetic particle imaging (MPI) system and method for use of iron-based nanoparticles in imaging and diagnosis
A method for diagnosing certain types of cancers provides a nanoparticle agent to be uptaken by cancer cells for diagnosis and treatment of certain cancers. A compound containing nanoparticles is directed toward a tumor site, and then a predetermined time period passes to allow the nanoparticles to be uptaken by the cancer cells. Imaging is then performed on the nanoparticles by an appropriate imaging device to determine the concentration of nanoparticles uptaken by the cancer cells. Finally, image data provided by the imaging device is analyzed to determine the concentration of nanoparticles and thereby determine whether a tumor is present. The nanoparticle agent can further be employed as a treatment of certain cancers. After the uptake of nanoparticles into the cells, a predetermined field applied to the nanoparticles for a sufficient period of time activates the magnetic cores of the nanoparticles to include hyperthermia-mediated destruction of the cancer cells.
1. A magnetic particle imaging (MPI) method of diagnosing certain cancers in which phagocytes selectively uptake iron-based nanoparticles, the MPI method comprising the steps of:
directing a compound containing the iron-based nanoparticles to be selectively delivered via phagocyte uptake to a tumor site containing cells;
allowing a predetermined time for the iron-based nanoparticles to be uptaken into the cells contained at the tumor site;
performing magnetic particle imaging using a magnetic particle imaging device in order to detect a concentration of iron-based nanoparticles uptaken into the cells;
analyzing image data provided by the magnetic particle imaging device in order to determine the concentration of iron-based nanoparticles indicative of the tumor site; and
applying a predetermined magnetic field to the iron-based nanoparticles for a sufficient period in order to activate a magnetic core of the iron-based nanoparticles, thereby inducing hyperthermia destruction of the cells.
2. The MPI method as set forth in claim 1 wherein the tumor site is ovarian cancer and the directing of the compound containing the iron-based nanoparticles is delivered into a peritoneal cavity.
3. The MPI method as set forth in claim 1 wherein the magnetic particle imaging device also comprises a magnetic resonance imaging (MRI) device.
4. The MPI method as set forth in claim 1 wherein the magnetic particle imaging device comprises a drive field coil and a pickup mechanism.
5. The MPI method as set forth in claim 1 , wherein allowing a predetermined time further comprises:
conducting a first measurement of the compound, at a first time indicative of an activity level of an immune system of a subject; and
conducting a second measurement of the compound, at a second time, the second time being later than the first time, and indicative of at least one region of the phagocyte uptake.
6. The MPI method as set forth in claim 1 wherein the iron-based nanoparticles are iron oxide nanoparticles.
7. The MPI method as set forth in claim 1 wherein the magnetic particle imaging device comprises:
drive and selection coils that generate a magnetic field which provides a sub-saturation region within a subject containing iron-based nanoparticles;
sensors that read signals from the iron-based nanoparticles adjacent to the sub-saturation region; and
supplemental coils that provide at least one of a static magnetic field offset and a gradient magnetic field so as to improve the localization characteristics of the signals whereby the magnetic particle imaging is improved.
8. The MPI method as set forth in claim 1 wherein the magnetic particle imaging device comprises:
a pair of drive coils that each generate a magnetic field which provides a sub-saturation region within a subject containing iron-based nanoparticles;
a control system that generates magnetic fields having each of two discrete frequencies in each of the pair of drive coils;
sensors that read signals from the iron-based nanoparticles adjacent to the sub-saturation region; and
a magnetic particle imaging system, operatively connected to the sensors and the control system, that localizes the nanoparticles based on the signals in response to information derived from the two discrete frequencies.
9. The MPI method as set forth in claim 8 wherein the magnetic particle imaging device further comprises an MRI constructed and arranged to derive an MRI image of the subject and wherein the combined magnetic particle and magnetic resonance imaging system is constructed and arranged to co-register an image of the MPI along with an the MRI image.
10. The MPI method as set forth in claim 1 further comprising providing an MRI that derives an MRI image of the subject and an image of the MPI along with an MRI image.
11. The MPI method as set forth in claim 1 wherein the magnetic particle imaging device comprises a spectroscopy device that determines the concentration of the iron-based nanoparticles.
12. The MPI method as set forth in claim 11 further comprising performing a further imaging of an area in which the concentration of the iron-based nanoparticles is localized in order to determine predetermined features of the tumor site.
13. The MPI method as set forth in claim 1 wherein the further imaging is performed using an MRI that is constructed and arranged in order to detect the iron-based nanoparticles.
14. A Magnetic Particle imaging(MPI) system configured for diagnosing certain cancers in which phagocytes selectively uptake iron-based nanoparticles comprising:
a compound containing the iron-based nanoparticles that is selectively delivered via phagocyte uptake to a tumor site containing cells; and
a magnetic particle imaging device that, a predetermined time after the iron-based nanoparticles are delivered, detects a concentration of the iron-based nanoparticles uptaken into the cells, and provides magnetic particle image data that allows a determination of the concentration of iron-based nanoparticles indicative of the tumor site; wherein the magnetic particle imaging device comprises:
drive and selection coils that generate a magnetic field which provides a sub-saturation region within a subject containing iron-based nanoparticles;
sensors that read signals from the iron-based nanoparticles adjacent to the sub-saturation region; and
supplemental coils that provide at least one of a static magnetic field offset and a gradient magnetic field so as to improve the localization characteristics of the signals whereby the magnetic particle imaging is improved.
15. The MPI system as set forth in claim 14 wherein the tumor site is at a peritoneal cavity that is being used for treating ovarian cancer.
16. The MPI system as set forth in claim 14 wherein the magnetic particle imaging device also comprises a magnetic resonance imaging (MRI) device.
17. The MPI system as set forth in claim 14 wherein the iron-based nanoparticles are iron oxide nanoparticles.
18. A Magnetic Particle Imaging (MPI) system configured for diagnosing certain cancers in which phagocytes selectively uptake iron-based nanoparticles comprising:
a compound containing the iron-based nanoparticles that is selectively delivered via phagocyte uptake to a tumor site containing cells; and
a magnetic particle imaging device that, a predetermined time after the iron-based nanoparticles are delivered, detects a concentration of the iron-based nanoparticles uptaken into the cells, and that provides image data that allows a determination of the concentration of the iron-based nanoparticles indicative of the tumor site;
wherein the magnetic particle imaging device comprises:
a pair of drive coils that each generate a magnetic field which provides a sub-saturation region within a subject containing the iron-based nanoparticles;
a control system that generates magnetic fields having each of two discrete frequencies in each of the pair of drive coils;
sensors that read signals from the iron-based nanoparticles adjacent to the sub-saturation region; and
a magnetic particle imaging system, operatively connected to the sensors and the control system, that localizes the iron-based nanoparticles based on the signals in response to information derived from the two discrete frequencies.
19. The MPI system as set forth in claim 18 wherein the magnetic particle imaging device further comprises an MRI constructed and arranged to derive an MRI image of the subject and wherein the combined magnetic particle and magnetic resonance imaging system is constructed and arranged to co-register an image of the MPI along with the MRI image.
20. The MPI system as set forth in claim 18 wherein the tumor site is at a peritoneal cavity that is being used for treating ovarian cancer.